Clinical trial
Determination of Pancreatic Steatosis Prevalence and Correlation With High-risk Cyst Features in Patients With Pre-malignant Pancreatic Cystic Neoplasms Using Magnetic Resonance Imaging and Endoscopic Ultrasound
NCT05334836 is registered in ClinicalTrials.gov with Chinese University of Hong Kong as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Determination of Pancreatic Steatosis Prevalence and Correlation With High-risk Cyst Features in Patients With Pre-malignant Pancreatic Cystic Neoplasms Using Magnetic Resonance Imaging and Endoscopic Ultrasound
- Lead sponsor
- Chinese University of Hong Kong
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- April 6, 2022
- Completion date
- April 30, 2026
- Enrollment
- 236 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
pancreatic cyst, pancreatic steatosis